Back to BAKER BROS. ADVISORS LP

GLUE
Showing 8 of 13 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in MONTE ROSA THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 4.3M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $71.5M as of 2026-Q1. GLUE represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$71.5M

Current Shares

4.3M

Total Value Change

+$53.1M

Total Shares Change

-570,359

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
4.3M
0.0%
$71.5M0.4%$17.96
0
2025-Q4
Decreased
4.3M
-11.6%
$68.1M0.4%$15.97
0
2025-Q3
Unchanged
4.9M
0.0%
$36.4M0.3%$7.31
0
2025-Q2
Unchanged
4.9M
0.0%
$22.2M0.2%$4.60
0
2025-Q1
Unchanged
4.9M
0.0%
$22.8M0.3%$5.10
0
2024-Q4
Unchanged
4.9M
0.0%
$34.1M0.4%$7.02
0
2024-Q3
Unchanged
4.9M
0.0%
$26.1M0.3%$5.17
0
2024-Q2
Unchanged
4.9M
0.0%
$18.4M0.2%$3.74
0

Other major holders of GLUE: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used